Edge Lab / HV-RSI Aristocrats / Details

HV-RSI Aristocrats

A defensive short-term mean-reversion book that buys oversold dips in the dividend-quality names of the S&P 500 — on real, survivorship-bias-free, total-return history.

← OverviewDetailsDeep Dive →

Executive summary

This is a part-time book. It buys a Dividend Aristocrat only after a sharp two-day sell-off (a 2-period RSI under 10), favours the most volatile of the candidates, sizes each by ATR, holds up to ten at once, and exits into the first close above the prior day’s high or after about a week. On an average day it has roughly 42% of the book at work and the rest in cash.

Because it is rarely fully invested and trades a thin per-trade edge, its headline return is modest. Net of costs it compounds at about 3.6% a year over 2005–2026; the S&P 500, fully invested, returned about 10.8%. On raw return it trails the index, plainly. What it offers instead is a shallower ride and a selection rule that carries real information: keep every rule the same but pick the names at random, and the book goes flat-to-negative net of costs — the real selection stays profitable, and the gap widens out-of-sample.

In one line: a defensive, dividend-quality sleeve — it does not out-compound the index, but it draws down about half as much and its stock selection beats a random book net of costs.

Reading a part-time book against a full-time index

Raw return is one lens, not the only one. Buy-and-hold puts 100% of your money to work every day; this puts about 42% to work on average and holds the rest in cash. It will trail on total return for that reason alone. The fairer questions are how deep the drawdowns get and whether the trades it takes are better than chance.

On drawdown the difference is real: a worst loss of about −22.8% net over 21 years, against roughly −55% for the S&P 500 in 2008–09. The book gained 2.5% in 2008 while the index fell 36%, and fell 8.6% in 2022 against the index’s 18.7% decline. It also lagged badly in strong-trend years (2013, 2019, 2021) — the same caution that limits the downside caps the upside. It does not out-compound the index, and is not presented as doing so.

Strategy net equity vs S&P 500 buy-and-hold, with strategy drawdown shading
The system (net, 2% cash) against S&P 500 buy-and-hold, both from $100k. The index ends far higher; the system’s line is shallower through the 2008–09 and 2022 declines.

Skill or luck? the random-selection test

Keep every rule, pick the names at random. Run the same universe, sizing, slot count, and exits, but choose which oversold-eligible names to buy at random instead of by the signal — averaged over 20 seeds. Net of the same costs that random book lands at a profit factor of 0.99 (about break-even) over the full window and 0.97 out-of-sample, while the real selection holds 1.07 and 1.10.

The selection’s measured effect is to roughly double the per-trade return and roughly halve the drawdown, rather than to lift the win rate, which is within about a point of random either way. The edge is real but modest, and it is clearest in the later, out-of-sample years — where the random book turns slightly negative net and the strategy does not.

Net CAGR and profit factor, strategy vs random selection, by window
Net (2% cash) CAGR and profit factor, strategy vs the random-selection book, across the full window and the in-sample / out-of-sample split.

How it works, in plain terms

Tested the hard way

Real history, including the losers. Membership is point-in-time and includes companies later dropped from the index when they failed to raise their dividend — so the result is not flattered by trading only today’s survivors. That matters for this index in particular, whose roster turns over precisely on dividend cuts.

Dividends are in the prices. All figures are on total-return data (dividends reinvested), consistent across the 145 covered names — essential for a dividend-focused universe, where leaving payouts out would both understate return and distort the oversold signal on ex-dividend days.

Costs and cash, stated plainly. Friction is 5 bps slippage per side plus a per-share commission, applied to the strategy and the random book alike; on a ~0.30% gross per-trade edge that roughly halves the per-trade return. Because the book sits ~58% in cash, the headline credits an explicit 2% on the idle balance — the Deep Dive also shows the 0% and 4% lines, since your own cash rate moves the number.

It holds up on unseen data. No parameters were fit, so splitting the history in two is a clean robustness check: the edge over the random book is intact in the later half (profit factor 1.10 vs 0.97). A live walk-forward is the natural next test.

View the full year-by-year and entry-timing detail

The calendar-year return and intra-year drawdown table, the full strategy-vs-random portfolio breakdown, and the entry-timing event study (oversold entries vs random entry days, across seven horizons) all live on the Deep Dive.

Who this is for

This fits a portfolio manager looking for a defensive, dividend-quality sleeve — a book valued for a shallower drawdown and a selection edge that survives costs, run on a fraction of the capital with the rest in cash earning yield or funding other strategies. It is a complement, prized for the shape of its returns rather than their size. As a standalone engine meant to beat the index, it is not that, and is not presented as that.

Let’s stress-test this for your mandate

No off-the-shelf backtest matches a real risk tolerance, capital constraint, or regulatory mandate. This study is a baseline demonstration of our research process. If you manage institutional capital, a family-office allocation, or a private portfolio, we can adapt the engine to your exact parameters.

Request a bespoke portfolio study

Or audit it yourself

Want the Python, the daily trade logs, and the data behind every number here? Get the full package — we email a personal download link.

For a bespoke study on your own universe, start a conversation — typically delivered within a few business days.

→ Full Deep Dive with the complete methodology, the random baselines, the calendar-year record, the entry-timing study, and the reproducibility check.